NCT02873000

Brief Summary

To evaluate the use of Incentive Spirometry in Non-critically Ill Hospitalized Patients With Shortness of Breath.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2015

Completed
9 months until next milestone

First Posted

Study publicly available on registry

August 19, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

April 1, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

April 18, 2017

Status Verified

April 1, 2017

Enrollment Period

2 months

First QC Date

November 20, 2015

Last Update Submit

April 14, 2017

Conditions

Keywords

incentive spirometryoutcomelength of stay,hospital complicationgeneral internal medicinehospital medicinenon-critically-ill

Outcome Measures

Primary Outcomes (1)

  • Change in Forced Vital Capacity (FVC)

    FVC will be measured on admission and at 48 hours

    From admission to the hospital up to 48 hours

Secondary Outcomes (4)

  • Subjective perception of respiratory distress

    From admission to the hospital up to 48 hours

  • Length of Stay (LOS)

    Starting on admission and until discharge from the hospital (up to 14 days)

  • Pulmonary complications

    Starting on admission and continuing for 7 days

  • Change in oxygen requirement

    Starting on admission and continuing for 72 hours

Study Arms (2)

Routine Care Group

NO INTERVENTION

Routine Care (R): Standard of care therapy based on admitting diagnosis

Experimental Group

EXPERIMENTAL

Intervention 1 (E1): addition of incentive spirometry every hour while awake; There will be a computerized protocol with specific instructions documenting: 1. compliance 2. patient position while using \[sitting up vs laying flat in bed\] 3. inspiratory volume attained 4. effort, motivation and compliance will subjectively be documented using a visual analogue 0-5 point scale.

Behavioral: Incentive Spirometry

Interventions

Incentive Spirometer is a tool that allows for deep breathing in a controlled setting while providing the user with visual feedback demonstrating the inspiratory volume of each breath.

Experimental Group

Eligibility Criteria

Age65 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients presenting to the ED with chief complaint of "shortness of breath," admitted to the hospitalist service
  • Age \>65 yrs of age

You may not qualify if:

  • Patients who can not follow instructions/use IS device
  • Cognitive impairment (Dementia/delirium/Developmental delay)
  • Heavy sedation
  • Inability to take part in deep breathing due to pain or diaphragmatic dysfunction
  • Suicide or psych watch
  • Patients under isolation
  • ICU admission or care within the last 48 hours
  • Recent hospitalization 30 days.
  • Intubation within the last 60 days
  • Routine care group patients that have IS prescribed to them by the admitting MD
  • Chronic/Home oxygen dependence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish Hospital of Cincinnati

Cincinnati, Ohio, 45236, United States

Location

MeSH Terms

Conditions

DyspneaPneumoniaPulmonary Disease, Chronic ObstructivePulmonary Atelectasis

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsRespiratory Tract InfectionsInfectionsLung DiseasesLung Diseases, ObstructiveChronic DiseaseDisease AttributesPathologic Processes

Study Officials

  • Imran Naqvi, MD

    Jewish Hospital of Cincinnati

    PRINCIPAL INVESTIGATOR
  • Nasim Motayar, MD

    Jewish Hospital of Cincinnati

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Imran Naqvi, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Hospitalist, Associated Program Director

Study Record Dates

First Submitted

November 20, 2015

First Posted

August 19, 2016

Study Start

April 1, 2017

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

April 18, 2017

Record last verified: 2017-04

Locations